West Nile Virus Antibody

West Nile virus antibody

10-1436 100 ug
EUR 425
Description: Mouse monoclonal West Nile virus antibody

West Laboratories manufactures the west nile virus antibody reagents distributed by Genprice. The West Nile Virus Antibody reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact West. Other West products are available in stock. Specificity: West Category: Nile Group: Virus Antibody

West Nile Virus

0.1mg
EUR 475

West Nile Virus

5x0.1mg
EUR 2060

West Nile Virus

0.1mg
EUR 355

West Nile Virus

5x0.1mg
EUR 1500

West Nile Virus

0.1mg
EUR 355

West Nile Virus

5x0.1mg
EUR 1500

West Nile Virus

0.1mg
EUR 355

Virus Antibody information

West Nile Virus Matrix Antibody

3431-002mg 0.02 mg
EUR 206.18
Description: West Nile Virus Matrix Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. However, when the viruses are inside of infected cells, the matrix protein exists in its "pre-M" form as a heterodimer with the envelope proteins. Cleavage of the "pre-M" protein to its mature form occurs during release of the virus; this cleavage leas to the dissociation of the heterodimers. The WNV receptor has recently been identified as alpha v beta 3 integrin.

West Nile Virus Matrix Antibody

3431-01mg 0.1 mg
EUR 523.7
Description: West Nile Virus Matrix Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. However, when the viruses are inside of infected cells, the matrix protein exists in its "pre-M" form as a heterodimer with the envelope proteins. Cleavage of the "pre-M" protein to its mature form occurs during release of the virus; this cleavage leas to the dissociation of the heterodimers. The WNV receptor has recently been identified as alpha v beta 3 integrin.

West Nile Virus Matrix Antibody

MBS150911-01mg 0.1mg
EUR 445

West Nile Virus Matrix Antibody

MBS150911-5x01mg 5x0.1mg
EUR 1965

West Nile Virus Matrix Antibody

MBS151132-01mg 0.1mg
EUR 445

West Nile Virus Matrix Antibody

MBS151132-5x01mg 5x0.1mg
EUR 1965

West Nile Virus Matrix Antibody

MBS9414400-01mL 0.1mL
EUR 495

West Nile Virus Matrix Antibody

MBS9414400-5x01mL 5x0.1mL
EUR 2075

West Nile Virus Matrix Antibody

MBS9408970-01mL 0.1mL
EUR 495

West Nile Virus Matrix Antibody

MBS9408970-5x01mL 5x0.1mL
EUR 2075

West Nile Virus Envelope Antibody

24282 100ul
EUR 479

West Nile Virus Envelope Antibody

24282-100ul 100ul
EUR 468

West Nile Virus Envelope Antibody

24283 100ul
EUR 479

West Nile Virus Envelope Antibody

24283-100ul 100ul
EUR 468

West Nile Virus Envelope Antibody

24284 100ul
EUR 479

West Nile Virus Envelope Antibody

24284-100ul 100ul
EUR 468

West Nile Virus Envelope Antibody

3437-002mg 0.02 mg
EUR 206.18
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin.